Providing credible, evidence-based information about medical technologies, treatments, and models of care

About CTAF

CTAF has long been recognized as one of the leading technology assessment programs in the country. In 2013, CTAF became a core program of the Institute for Clinical and Economic Review, and its approach has now been adapted to broaden stakeholder engagement and improve the application of CTAF products in practice and policy. Learn more »


Recent Assessments

Attend a Meeting

July 11, 2014
Los Angeles, CA (Sheraton Gateway Hotel at LAX)
CTAF will be examining various treatment options for migraine headaches. The topic is timely given the recent FDA approval of a new hand–held device producing transcranial magnetic stimulation (TMS) for treating migraines. CTAF's review will include evidence on major treatment options (i.e., this new device, various drug regimens, and alternative/ complementary therapies). CTAF’s public deliberation of the evidence will provide clarity and guidance to clinicians, insurers, and patients confronted with decisions on how best to treat migraines.

Email Updates

Sign up to receive email notifications of upcoming CTAF meetings and new assessments. All fields required.